WO2006038690A1 - Functional food and drink - Google Patents

Functional food and drink Download PDF

Info

Publication number
WO2006038690A1
WO2006038690A1 PCT/JP2005/018633 JP2005018633W WO2006038690A1 WO 2006038690 A1 WO2006038690 A1 WO 2006038690A1 JP 2005018633 W JP2005018633 W JP 2005018633W WO 2006038690 A1 WO2006038690 A1 WO 2006038690A1
Authority
WO
WIPO (PCT)
Prior art keywords
absorbance
red
absorption spectrum
propolis
vicinity
Prior art date
Application number
PCT/JP2005/018633
Other languages
French (fr)
Japanese (ja)
Inventor
Naomi Kuze
Masato Kawaguchi
Taisuke Koike
Isao Horiuchi
Original Assignee
Japan Applied Microbiology Research Institute Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Applied Microbiology Research Institute Ltd. filed Critical Japan Applied Microbiology Research Institute Ltd.
Priority to JP2006539345A priority Critical patent/JPWO2006038690A1/en
Publication of WO2006038690A1 publication Critical patent/WO2006038690A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Definitions

  • the present invention particularly relates to a functional food or drink.
  • Patent Document 1 JP-A-5-316968
  • Patent Document 2 JP 2004-159655 A
  • An object of the present invention is to provide a functional food or drink that can eliminate such inconveniences.
  • the present invention has the following configurations to solve the above problems.
  • the gist of the invention of claim 1 is a food or drink product containing red propolis as a raw material
  • Eyes ij ti red-mouthed hollis is characterized by having at least one of Strypnnodendron aastnngens ⁇ 3 ⁇ 4chinus molie, Rhi zophora mangle, and Manikara elata as origin plant,
  • the food or drink has antibacterial action, antioxidant action, antiallergic action, antitumor action, or liver function. It exists in the food / beverage products characterized by having one or more functional effects of the protective effect of ability disorder.
  • the gist of the invention described in claim 2 is that the red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, and has a specific power ⁇ or more with the absorbance in the vicinity of the stable region, and the visible region.
  • the gist of the invention described in claim 3 is an antibacterial agent containing red propolis as an active ingredient
  • the antibacterial agent resides in an antibacterial agent characterized by being used for food and drink, cosmetics, or pharmaceuticals.
  • the gist of the invention described in claim 4 is that the red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, and has a specific power ⁇ or more with the absorbance in the vicinity of the stable region, and the visible region. 4.
  • the gist of the invention described in claim 5 is an antioxidizing agent containing red propolis as an active ingredient
  • the antioxidant is an antioxidant for use in foods and drinks, cosmetics, or pharmaceuticals.
  • the gist of the invention of claim 6 is that the red propolis has an absorption maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, and has a specific power with an absorbance in the vicinity of the stable region ⁇ or more
  • the gist of the invention of claim 7 is an anti-allergic agent containing red propolis as an active ingredient
  • the antiallergic agent is an antiallergic agent characterized in that it is used for foods and drinks, cosmetics or pharmaceuticals.
  • the gist of the invention described in claim 8 is that the red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, has a specific power ⁇ or more with the absorbance in the vicinity of the stable region, and is visible.
  • the absorption spectrum has a maximum value of absorbance around a wavelength of 500 nm, and a ratio of the absorbance in the nearby stable region is 5 or more.
  • the gist of the invention described in claim 9 is an antitumor agent containing red propolis as an active ingredient
  • the antitumor agent is an antitumor agent characterized in that it is used for foods and drinks or pharmaceuticals.
  • the gist of the invention of claim 10 is that the red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, has a specific power ⁇ or more with the absorbance in the vicinity of the stable region, and has a visible region.
  • the gist of the invention described in claim 11 is that the liver contains red propolis as an active ingredient.
  • a dysfunction protective agent is that the liver contains red propolis as an active ingredient.
  • the liver dysfunction protective agent is for a liver dysfunction protective agent characterized in that it is used for foods and drinks or pharmaceuticals.
  • the gist of the invention of claim 12 is that the red propolis has an absorption spectrum at a wavelength near 280 nm in the ultraviolet absorption spectrum, has a specific power ⁇ or more with the absorbance in the nearby stable region, and is visible.
  • a functional food or drink containing a red propolis derived from a specific plant of origin as a raw material can be easily provided. Therefore, sufficient antibacterial action, antioxidant action, and antiallergic action are provided.
  • functional foods and drinks having an antitumor action or liver dysfunction protection action can be provided. By taking this food and drink, it becomes possible to improve health.
  • an antibacterial agent an antioxidant, an antiallergic agent, an antitumor agent, or a liver dysfunction protective agent
  • a safe antibacterial agent, antioxidant, antiallergic agent, antitumor agent, or liver dysfunction protective agent having functionality and excellent practicality.
  • FIG. 1 is a bar graph showing the anti-acidic ability of various propolises.
  • FIG. 2 is a graph showing the spectral characteristics (ultraviolet region) of two types of propolis.
  • FIG. 3 is a graph showing spectral characteristics (visible region) of two types of propolis.
  • FIG. 4 shows an antibacterial action (MRSA) of an antibacterial agent in Example 3 of the present invention.
  • FIG. 5 shows an antibacterial action (MSSA) of an antibacterial agent in Example 3 of the present invention.
  • FIG. 6 shows the antibacterial action (Staphylococcus epidermidis) of the antibacterial agent in Example 3 of the present invention.
  • FIG. 7 shows the liver dysfunction protective action of the liver dysfunction protective agent in Example 7 of the present invention.
  • FIG. 8 shows the antitumor effect of an antitumor agent in Example 8 of the present invention.
  • the functional food and drink, antibacterial agent, antioxidant, antiallergic agent, antitumor agent, and liver dysfunction protective agent according to the present invention contain Brazilian red propolis as an active ingredient.
  • This red propolis is different from normal propolis in that it has a red color. This is the origin of the plant, a strypnnodendron adstrmgens, 3 ⁇ 4chmus molie, Rhizopnora m angle, Manikara elata, or multiple species of these. Because it is.
  • Stryphnodendron adstringens is a special deciduous sub-tree of Brazil that has vascular contraction.
  • Schinus molle is an evergreen Takagi of the Japanese name “Pepper botanus”, and scabbard is used for astringents, wounds, tonics, translucents, diuretics, anti-diarrhea, swelling medicines, etc.
  • Rhizophora mangle is a Japanese name “American hirugi”, a high tree that has astringent and hemostatic properties and is also used for tumors.
  • Manikara elata is an ultra-high tree produced in Brazil and is used for tumor swelling and softening. All of these origin plants have red crusts and are considered to be the origin plant of the red propolis used in the present invention.
  • this red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm (275 to 285 nm) in the ultraviolet absorption spectrum, and has a stable region (wavelength of 320 nm). Spectral characteristics with a ratio of absorbance of (near) to 1 or more.
  • this red propolis has a maximum absorbance at a wavelength of about 50 Onm (490-510 nm) in the visible absorption spectrum, and a stable region in the vicinity (around a wavelength of 650 nm).
  • the spectral characteristics of Brazilian yellow propolis are shown in phantom lines in Fig. 2.
  • the absorbance means a common logarithm of the reciprocal of the transmittance.
  • This red propolis has an excellent antibacterial action, antibacterial action, antioxidant action, antiallergic action, antitumor action, and liver dysfunction protective action not found in conventional propolis. It can be used as functional foods and drinks that are expected to work, and as antibacterial agents, antioxidants, antiallergic agents, antitumor agents, and liver dysfunction protective agents. [0014] When this red propolis is used as the above-mentioned functional food or drink, it may be directly added to the food or drink, or an active ingredient extracted by hot water extraction or solvent extraction is added to the food or drink. You may do it.
  • the active ingredient in the red propolis bulk contains both fat-soluble and water-soluble ingredients, so it is possible to extract both fat-soluble and water-soluble active ingredients such as liquid carbon dioxide extraction. It is preferable to purify by a simple method.
  • the antibacterial agent, the antioxidant, and the antiallergic agent can be used for various uses such as food and drink, cosmetics, and pharmaceuticals.
  • food and drink products include processed agricultural products such as vegetable juice and tofu, processed fishery products such as sausages and chikuwa, processed livestock products such as cheese and ham, pickles, Japanese confectionery, Western confectionery, and other livestock feeds.
  • Cosmetics include bathing agents, shampoos, rinses, emulsions, hair creams, lipsticks and toothpastes.
  • mouthwash food poisoning, internal medicine for infectious diseases, wound medicine, external salve for burns, nasal spray and the like.
  • the antitumor agent and hepatic dysfunction protective agent can be used for various uses such as food and drink as described above.
  • antibacterial agents antioxidant agents, antiallergic agents, antitumor agents, and hepatic dysfunction protective agents have various dosage forms such as powders, granules, tablets, etc., depending on their use and usage. It can be a shape.
  • the concentration of the Brazilian red populus was varied in 6 steps within a range of 100 to 5,000 ⁇ g / mL. At this time, it was examined how the growth of the test bacteria in the medium changes. For comparison, the same measurement was performed for Cuban red propolis and Brazilian yellow propolis. Specifically, the sample was dissolved in 80% ethanol (EtOH), and the growth was observed after inoculating the test bacteria on pour medium (plate agar medium) of each concentration. The measurement results are summarized in Table 1.
  • E.coli Escherichia coli
  • P.aerugmosa Peudomonas aeruginosa
  • E. faecahs Enterococcus faec alis
  • S. aureus 500 100 or less 100 or less 100 or less 100 or less.
  • Example 3 In the same manner as in Example 1, the experiment was carried out with the propolis concentration varied in the range of 40 3000 ⁇ g ZmL, and the minimum growth inhibitory concentrations of various test bacteria were calculated. There are five types of test bacteria: E. coli P. aeruginosa ⁇ S. aureus ⁇ Bacillus subtillis (abbreviated as ⁇ ⁇ F B. subtillis) and Candid a albicanc (hereinafter abbreviated as C. albicanc). Was used. The results are shown in Table 3.
  • the minimum growth inhibitory concentration (MIC) of 5,000 ⁇ g ZmL for Cuban red propolis and Brazilian propolis is 5,000 ⁇ g ZmL.
  • the Brazilian red propolis had a minimum growth inhibitory concentration (MIC) of 2,500 ⁇ gZmL, whereas the growth inhibition was not observed even at 5,000 ⁇ gZmL.
  • the minimum growth inhibitory concentration (MIC) of Brazilian yellow propolis is 1,000 ⁇ gZmL, while that of Brazilian red propolis is the minimum growth inhibitory concentration ( MIC) dropped significantly to below 100 ⁇ gZmL.
  • Brazilian yellow propolis has a minimum inhibitory concentration (MIC) of 500 ⁇ gZmL, while Brazilian red propolis has a minimum inhibitory concentration (MIC) of 40 to 80 ⁇ m. It was significantly lower than gZmL.
  • the concentration is 500 ⁇ gZmL or more, the antibacterial activity is improved against all 6 types of test bacteria, If the value is 1,000 g ZmL or more and 2,500 gZmL or more, the tendency becomes remarkable. Therefore, the optimal concentration of red propolis produced in Brazil is 100 gZmL or more when using E. faecalis, S. aureus, and C. albicanc from the viewpoint of antibacterial properties. When used for seeds, it is 500 gZmL or more (preferably 1,000 / z gZmL or more, more preferably 2,500 ⁇ gZmL or more).
  • test bacteria examples include Methicillin Resistant Staphylococcus aureus (methicillin metastatic Staphylococcus aureus, hereinafter abbreviated as MRSA), Methicillin Sensitive Staphylococcus aureus (methicillin-sensitive Staphylococcus aureus, hereinafter abbreviated as MSSA), Three types of Staphylococcus epider midis (Staphylococcus epidermidis) were used.
  • MRSA Methicillin Resistant Staphylococcus aureus
  • MSSA Methicillin-sensitive Staphylococcus aureus
  • Three types of Staphylococcus epider midis Staphylococcus epidermidis were used.
  • the sample extracted with liquid carbon dioxide gas is 80% ethanol (EtOH). After inoculating the test bacteria in pour medium (plate agar medium) of each concentration, the growth state was observed. The measurement results are shown in Figs.
  • the red propolis administration group showed a growth inhibition rate of 80% or more at 200 gZmL. This effect was higher than that of conventional propolis.
  • the antioxidant properties were measured using DPPH radical scavenging ability mainly measuring fat-soluble substances.
  • the number of samples is 2 (Brazilian red (1), Brazilian red (2))
  • the number of samples is 2 (Cuban red (1), Cuban red (2))
  • the number of samples is 1 (Brazilian yellow)
  • antiallergic activity was measured using whole anaphylactic shock-induced mice.
  • mice were administered compound48 / 80.
  • propolis a water-extracted powder extracted with hot bulk water was used for oral administration to mice.
  • a control a control that was given water instead of propolis was used as a control. The results are shown in Table 5.
  • liver dysfunction protective action was measured using experimental hepatopathy-induced rats. Rats were administered tetrasalt carbon dioxide to induce experimental liver injury.
  • the GPT value was 549 in the order of control, yellow propolis, and red propolis, respectively.
  • the inbred mouse C57BLZ6N, female, and 6 weeks of age tested were preliminarily raised for one week, and the average body weight of each group was one.
  • Six groups were composed of 10 animals per group.
  • prepare control (purified water), propolis A of other companies' propolis products manufactured: Kyowa Hakko Kogyo Co., Ltd., sales: San Hells Co., Ltd.
  • red propolis hot water extract of the present invention prepare a mouse body weight of 800 mg / kg and administer once a day using an oral sonde. Started.
  • EL-4 mouse lymphoma
  • EL-4 mouse lymphoma
  • the tumor growth inhibitory effect was 12.1% for the other company's product and 54.7% for the red propolis hot water extract of the present invention. It was observed .
  • the red propolis-derived antitumor agent of the present invention can be expected to have a high antitumor effect.
  • the functional food or drink product containing the red propolis of the present invention as a raw material has a sufficient antibacterial action, antioxidant action, antiallergic action, antitumor action, or liver dysfunction protective action. Food and drink can be provided relatively easily. Taking these foods and drinks can improve your health.
  • an antibacterial agent an antioxidant, an antiallergic agent, an antitumor agent, or a liver dysfunction protective agent. It is possible to provide a safe antibacterial agent, antioxidant, antiallergic agent, antitumor agent, or liver dysfunction protective agent that has functionality and is excellent in safety and practicality.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Abstract

A functional food and drink having been enhanced with respect to the functions such as antibacterial, antioxidant, antiallergic, and antitumor properties and protection against hepatic function disorder. There is provided a food or drink containing red propolis as a raw ingredient, characterized in that the original plant of the red propolis is at least one member selected from among Stryphnodendron adstringens, Schinus molle, Rhizophora mangle and Manikara elata, and that the food or drink has at least one functional activity selected from among antibacterial, antioxidant, antiallergic, and antitumor properties and protection against hepatic function disorder. Accordingly, over those of the conventional propolis, the antibacterial, antioxidant, antiallergic, and antitumor properties and protection against hepatic function disorder have been enhanced.

Description

明 細 書  Specification
機能性飲食品  Functional food and drink
技術分野  Technical field
[0001] 本発明は、特に機能性飲食品に関するものである。  [0001] The present invention particularly relates to a functional food or drink.
背景技術  Background art
[0002] 近年、この種の製品にお ヽては、その安全性確保や健康維持の観点から、抗菌性 や抗酸ィ匕性などに代表される機能性を高めることが社会的にますます要望される傾 向にある。しかし、この種の製品の有する機能性は、必ずしも十分な効能を発現する までには至っておらず、一層の高機能化が強く望まれている。  [0002] In recent years, it has become increasingly social to improve the functionality of products of this type, such as antibacterial and anti-acidic properties, from the viewpoint of ensuring safety and maintaining health. The trend is as desired. However, the functionality possessed by this type of product has not yet achieved sufficient efficacy, and further enhancement of functionality is strongly desired.
[0003] そこで、こうした要望に応えるベぐ特許文献 1、 2に開示された従来技術などが提 案されている。  [0003] Therefore, conventional techniques disclosed in Patent Documents 1 and 2 that respond to such demands have been proposed.
特許文献 1 :特開平 5— 316968号公報  Patent Document 1: JP-A-5-316968
特許文献 2 :特開 2004— 159655号公報  Patent Document 2: JP 2004-159655 A
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] ところが、これらの従来技術では、抽出や製法上、力なり複雑な工程を必要とするた め、実用性に乏しいという欠点があった。 [0004] However, these conventional techniques have a drawback that they are not practical because they require complicated and complicated processes for extraction and production.
[0005] 本発明は、このような不都合を解消することが可能な機能性飲食品を提供すること を目的とする。 [0005] An object of the present invention is to provide a functional food or drink that can eliminate such inconveniences.
課題を解決するための手段  Means for solving the problem
[0006] 本発明は上記課題を解決すベぐ以下に掲げる構成とした。 [0006] The present invention has the following configurations to solve the above problems.
請求項 1記載の発明の要旨は、赤色プロポリスが原材料として含まれている飲食品 であって、  The gist of the invention of claim 1 is a food or drink product containing red propolis as a raw material,
目 ij ti赤色フ—口ホリスは、 Strypnnodendron aastnngens^ ¾chinus molie、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes ij ti red-mouthed hollis is characterized by having at least one of Strypnnodendron aastnngens ^ ¾chinus molie, Rhi zophora mangle, and Manikara elata as origin plant,
前記飲食品は抗菌作用、抗酸化作用、抗アレルギー作用、抗腫瘍作用、又は肝機 能障害保護作用のいずれか 1つ以上の機能性作用を有することを特徴とする飲食品 に存する。 The food or drink has antibacterial action, antioxidant action, antiallergic action, antitumor action, or liver function. It exists in the food / beverage products characterized by having one or more functional effects of the protective effect of ability disorder.
請求項 2記載の発明の要旨は、前記赤色プロポリスは、紫外部吸収スペクトルで、 波長 280nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比力 ^以上 であり、かつ可視部吸収スペクトルで、波長 500nm付近に吸光度の極大値を持ち、 近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 1に記載の飲 食品に存する。  The gist of the invention described in claim 2 is that the red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, and has a specific power ^ or more with the absorbance in the vicinity of the stable region, and the visible region. 2. The food / beverage according to claim 1, wherein the absorption spectrum has a maximum absorbance near a wavelength of 500 nm and a ratio of the absorbance in the nearby stable region is 5 or more.
請求項 3記載の発明の要旨は、赤色プロポリスが有効成分として含まれている抗菌 剤であって、  The gist of the invention described in claim 3 is an antibacterial agent containing red propolis as an active ingredient,
目 ij己赤色プロポリス ίま、 Stryphnoaendron adstringens^ ¾chmus molle、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Ij self-red propolis ί, Stryphnoaendron adstringens ^ ¾chmus molle, Rhi zophora mangle, and Manikara elata
前記抗菌剤は飲食品用、化粧品用または医薬品用であることを特徴とする抗菌剤 に存する。  The antibacterial agent resides in an antibacterial agent characterized by being used for food and drink, cosmetics, or pharmaceuticals.
請求項 4記載の発明の要旨は、前記赤色プロポリスは、紫外部吸収スペクトルで、 波長 280nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比力 ^以上 であり、かつ可視部吸収スペクトルで、波長 500nm付近に吸光度の極大値を持ち、 近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 3に記載の抗 菌剤に存する。  The gist of the invention described in claim 4 is that the red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, and has a specific power ^ or more with the absorbance in the vicinity of the stable region, and the visible region. 4. The antibacterial agent according to claim 3, wherein the absorption spectrum has a maximum absorbance near a wavelength of 500 nm and a ratio of the absorbance in the vicinity of the stable region is 5 or more.
請求項 5記載の発明の要旨は、赤色プロポリスが有効成分として含まれている抗酸 化剤であって、  The gist of the invention described in claim 5 is an antioxidizing agent containing red propolis as an active ingredient,
目 ij己赤色プロポリス ίま、 Stryphnoaendron adstringens^ ¾chmus molle、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Ij self-red propolis ί, Stryphnoaendron adstringens ^ ¾chmus molle, Rhi zophora mangle, and Manikara elata
前記抗酸化剤は飲食品用、化粧品用または医薬品用であることを特徴とする抗酸 化剤に存する。  The antioxidant is an antioxidant for use in foods and drinks, cosmetics, or pharmaceuticals.
請求項 6記載の発明の要旨は、前記赤色プロポリスは、紫外部吸収スペクトルで、 波長 280nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比力 ^以上 であり、かつ可視部吸収スペクトルで、波長 500nm付近に吸光度の極大値を持ち、 近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 5に記載の抗 酸化剤に存する。 The gist of the invention of claim 6 is that the red propolis has an absorption maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, and has a specific power with an absorbance in the vicinity of the stable region ^ or more The antioxidant according to claim 5, wherein the antioxidant has a maximum absorbance near a wavelength of 500 nm in the visible absorption spectrum, and the ratio of the absorbance in the nearby stable region is 5 or more. Exist.
請求項 7記載の発明の要旨は、赤色プロポリスが有効成分として含まれている抗ァ レルギ一剤であって、  The gist of the invention of claim 7 is an anti-allergic agent containing red propolis as an active ingredient,
目 li 己赤色プロポリス ίま、 Stryphnoaendron adstringens、 ¾chmus molle、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes li self red propolis ίMA, Stryphnoaendron adstringens, ¾chmus molle, Rhi zophora mangle, and Manikara elata
前記抗アレルギー剤は飲食品用、化粧品用または医薬品用であることを特徴とす る抗アレルギー剤に存する。  The antiallergic agent is an antiallergic agent characterized in that it is used for foods and drinks, cosmetics or pharmaceuticals.
請求項 8記載の発明の要旨は、前記赤色プロポリスは、紫外部吸収スペクトルで、 波長 280nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比力 ^以上 であり、かつ可視部吸収スペクトルで、波長 500nm付近に吸光度の極大値を持ち、 近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 7に記載の抗ァ レルギ一剤に存する。  The gist of the invention described in claim 8 is that the red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, has a specific power ^ or more with the absorbance in the vicinity of the stable region, and is visible. 8. The antiallergic agent according to claim 7, wherein the absorption spectrum has a maximum value of absorbance around a wavelength of 500 nm, and a ratio of the absorbance in the nearby stable region is 5 or more.
請求項 9記載の発明の要旨は、赤色プロポリスが有効成分として含まれている抗腫 瘍剤であって、  The gist of the invention described in claim 9 is an antitumor agent containing red propolis as an active ingredient,
目 li 己赤色プロポリス ίま、 Stryphnoaendron adstringens、 ¾chmus molle、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes li self red propolis ίMA, Stryphnoaendron adstringens, ¾chmus molle, Rhi zophora mangle, and Manikara elata
前記抗腫瘍剤は飲食品用または医薬品用であることを特徴とする抗腫瘍剤に存す る。  The antitumor agent is an antitumor agent characterized in that it is used for foods and drinks or pharmaceuticals.
請求項 10記載の発明の要旨は、前記赤色プロポリスは、紫外部吸収スペクトルで、 波長 280nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比力 ^以上 であり、かつ可視部吸収スペクトルで、波長 500nm付近に吸光度の極大値を持ち、 近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 9に記載の抗 腫瘍剤に存する。  The gist of the invention of claim 10 is that the red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm in the ultraviolet absorption spectrum, has a specific power ^ or more with the absorbance in the vicinity of the stable region, and has a visible region. 10. The antitumor agent according to claim 9, wherein the absorption spectrum has a maximum absorbance near a wavelength of 500 nm and a ratio of the absorbance in the vicinity of the stable region is 5 or more.
請求項 11記載の発明の要旨は、赤色プロポリスが有効成分として含まれている肝 機能障害保護剤であって、 The gist of the invention described in claim 11 is that the liver contains red propolis as an active ingredient. A dysfunction protective agent,
目 ij ti赤色プロポリス ίま、 Stryphnodendron adstringens、 Schinus molle、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes ij ti red propolis ί, Stryphnodendron adstringens, Schinus molle, Rhi zophora mangle, and Manikara elata
前記肝機能障害保護剤は飲食品用または医薬品用であることを特徴とする肝機能 障害保護剤に存する。  The liver dysfunction protective agent is for a liver dysfunction protective agent characterized in that it is used for foods and drinks or pharmaceuticals.
請求項 12記載の発明の要旨は、前記赤色プロポリスは、紫外部吸収スペクトルで、 波長 280nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比力 ^以上 であり、かつ可視部吸収スペクトルで、波長 500nm付近に吸光度の極大値を持ち、 近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 11に記載の肝 機能障害保護剤に存する。 発明の効果  The gist of the invention of claim 12 is that the red propolis has an absorption spectrum at a wavelength near 280 nm in the ultraviolet absorption spectrum, has a specific power ^ or more with the absorbance in the nearby stable region, and is visible. 12. The liver dysfunction protective agent according to claim 11, wherein the absorption spectrum has a maximum absorbance at a wavelength of about 500 nm and a ratio of the absorbance in the vicinity of the stable region is 5 or more. The invention's effect
[0007] 本発明によれば、特定の起源植物由来の赤色プロポリスが原材料として含まれて いる機能性飲食品を容易に提供できるため、十分な抗菌作用、抗酸化作用、抗ァレ ルギ一作用、抗腫瘍作用、又は肝機能障害保護作用を備えた機能性飲食品を提供 することができる。この飲食品を摂取することで、健康を増進することが可能となる。  [0007] According to the present invention, a functional food or drink containing a red propolis derived from a specific plant of origin as a raw material can be easily provided. Therefore, sufficient antibacterial action, antioxidant action, and antiallergic action are provided. In addition, functional foods and drinks having an antitumor action or liver dysfunction protection action can be provided. By taking this food and drink, it becomes possible to improve health.
[0008] また、特定の起源植物由来の赤色プロポリスが有効成分として含まれて 、る抗菌剤 、抗酸化剤、抗アレルギー剤、抗腫瘍剤、又は肝機能障害保護剤を提供できるため 、十分な機能性を備え、かつ実用性にも優れた安全な抗菌剤、抗酸化剤、抗アレル ギー剤、抗腫瘍剤、又は肝機能障害保護剤を提供することができる。  [0008] Further, since red propolis derived from a plant of a specific origin is contained as an active ingredient, an antibacterial agent, an antioxidant, an antiallergic agent, an antitumor agent, or a liver dysfunction protective agent can be provided. It is possible to provide a safe antibacterial agent, antioxidant, antiallergic agent, antitumor agent, or liver dysfunction protective agent having functionality and excellent practicality.
図面の簡単な説明  Brief Description of Drawings
[0009] [図 1]各種のプロポリスの抗酸ィ匕能を示す棒グラフである。 [0009] FIG. 1 is a bar graph showing the anti-acidic ability of various propolises.
[図 2] 2種類のプロポリスのスペクトル特性 (紫外線領域)を表すグラフである。  FIG. 2 is a graph showing the spectral characteristics (ultraviolet region) of two types of propolis.
[図 3] 2種類のプロポリスのスペクトル特性 (可視領域)を表すグラフである。  FIG. 3 is a graph showing spectral characteristics (visible region) of two types of propolis.
[図 4]本発明の実施例 3における抗菌剤の抗菌作用(MRSA)を示す。  FIG. 4 shows an antibacterial action (MRSA) of an antibacterial agent in Example 3 of the present invention.
[図 5]本発明の実施例 3における抗菌剤の抗菌作用(MSSA)を示す。  FIG. 5 shows an antibacterial action (MSSA) of an antibacterial agent in Example 3 of the present invention.
[図 6]本発明の実施例 3における抗菌剤の抗菌作用(表皮ブドウ球菌)を示す。  FIG. 6 shows the antibacterial action (Staphylococcus epidermidis) of the antibacterial agent in Example 3 of the present invention.
[図 7]本発明の実施例 7における肝機能障害保護剤の肝機能障害保護作用を示す。 [図 8]本発明の実施例 8における抗腫瘍剤の抗腫瘍作用を示す。 FIG. 7 shows the liver dysfunction protective action of the liver dysfunction protective agent in Example 7 of the present invention. FIG. 8 shows the antitumor effect of an antitumor agent in Example 8 of the present invention.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0010] 以下、本発明の実施形態を図面に基づいて説明する。 Hereinafter, embodiments of the present invention will be described with reference to the drawings.
[0011] 本発明に係る機能性飲食品、抗菌剤、抗酸化剤、抗アレルギー剤、抗腫瘍剤、肝 機能障害保護剤には、ブラジル産の赤色プロポリスが有効成分として含まれている。 この赤色プロポリスは、通常のプロポリスと異なり赤色を呈している力 これはその起 源植物 a Strypnnodendron adstrmgens、 ¾chmus molie、 Rhizopnora m angle, Manikara elataのいずれ力 或いはこれらのうちの複数種を起源植物とし ているためである。  [0011] The functional food and drink, antibacterial agent, antioxidant, antiallergic agent, antitumor agent, and liver dysfunction protective agent according to the present invention contain Brazilian red propolis as an active ingredient. This red propolis is different from normal propolis in that it has a red color. This is the origin of the plant, a strypnnodendron adstrmgens, ¾chmus molie, Rhizopnora m angle, Manikara elata, or multiple species of these. Because it is.
Stryphnodendron adstringens は、ブラジル特産の落葉亜高木で、血管の収 縮作用を有する。 Schinus molle は、和名「コショウボタ」の常緑高木であり、榭皮 は収斂剤、傷薬、強壮剤、通経剤、利尿剤、下痢止め、腫れ物薬などに用いられる。 Rhizophora mangle は、和名「アメリカヒルギ」の高木で、収斂性、止血作用を有 し腫瘍にも用いられる。 Manikara elata は、ブラジル特産の超高木であり、腫瘍 の腫れや軟化に用いられる。これら起源植物のいずれも、榭皮が赤色を呈しており、 本発明に用いられる赤色プロポリスの起源植物であるものと考えられて 、る。  Stryphnodendron adstringens is a special deciduous sub-tree of Brazil that has vascular contraction. Schinus molle is an evergreen Takagi of the Japanese name “Pepper botanus”, and scabbard is used for astringents, wounds, tonics, translucents, diuretics, anti-diarrhea, swelling medicines, etc. Rhizophora mangle is a Japanese name “American hirugi”, a high tree that has astringent and hemostatic properties and is also used for tumors. Manikara elata is an ultra-high tree produced in Brazil and is used for tumor swelling and softening. All of these origin plants have red crusts and are considered to be the origin plant of the red propolis used in the present invention.
[0012] またこの赤色プロポリスは、図 2に実線のグラフで示すように、紫外部吸収スペクトル で、波長 280nm付近(275〜285nm)に吸光度の極大値を持ち、近傍の安定域 (波 長 320nm付近)の吸光度との比が 1以上であるスペクトル特性を示す。また、この赤 色プロポリスは、図 3に実線のグラフで示すように、可視部吸収スペクトルで、波長 50 Onm付近 (490〜510nm)に吸光度の極大値を持ち、近傍の安定域(波長 650nm 付近)の吸光度との比が 5以上であるスペクトル特性を示す。比較のため、ブラジル 産の黄色プロポリスのスペクトル特性について、図 2に想像線のグラフで示す。ここで 、吸光度とは、透過率の逆数の常用対数を意味する。  In addition, as shown by the solid line graph in FIG. 2, this red propolis has an absorption spectrum maximum in the vicinity of a wavelength of 280 nm (275 to 285 nm) in the ultraviolet absorption spectrum, and has a stable region (wavelength of 320 nm). Spectral characteristics with a ratio of absorbance of (near) to 1 or more. In addition, as shown by the solid line graph in Fig. 3, this red propolis has a maximum absorbance at a wavelength of about 50 Onm (490-510 nm) in the visible absorption spectrum, and a stable region in the vicinity (around a wavelength of 650 nm). ) Shows a spectral characteristic whose ratio to the absorbance is 5 or more. For comparison, the spectral characteristics of Brazilian yellow propolis are shown in phantom lines in Fig. 2. Here, the absorbance means a common logarithm of the reciprocal of the transmittance.
[0013] この赤色プロポリスは、従来のプロポリスに見られない優れた抗菌作用、抗菌作用、 抗酸化作用、抗アレルギー作用、抗腫瘍作用、および肝機能障害保護作用を有して いるため、これら各種作用を期待した機能性飲食品として、また抗菌剤、抗酸化剤、 抗アレルギー剤、抗腫瘍剤、肝機能障害保護剤として利用することができる。 [0014] この赤色プロポリスを上記の機能性飲食品として用いる際には、直接飲食品に添カロ しても良ぐまた熱水抽出や溶剤抽出などによって有効成分を抽出したものを飲食品 に添加しても良い。赤色プロポリスの原塊に含まれる有効成分は、脂溶性のものと水 溶性のものと双方が含まれているため、液ィ匕炭酸ガス抽出等の脂溶性、水溶性双方 の有効成分を抽出可能な方法によって精製されることが好ましい。 [0013] This red propolis has an excellent antibacterial action, antibacterial action, antioxidant action, antiallergic action, antitumor action, and liver dysfunction protective action not found in conventional propolis. It can be used as functional foods and drinks that are expected to work, and as antibacterial agents, antioxidants, antiallergic agents, antitumor agents, and liver dysfunction protective agents. [0014] When this red propolis is used as the above-mentioned functional food or drink, it may be directly added to the food or drink, or an active ingredient extracted by hot water extraction or solvent extraction is added to the food or drink. You may do it. The active ingredient in the red propolis bulk contains both fat-soluble and water-soluble ingredients, so it is possible to extract both fat-soluble and water-soluble active ingredients such as liquid carbon dioxide extraction. It is preferable to purify by a simple method.
[0015] この抗菌剤、抗酸化剤、抗アレルギー剤の用途は、飲食品用、化粧品用、医薬品 用など各種の用途が考えられる。ここで、飲食品用としては、野菜ジュース、豆腐等 の農産加工品、ソーセージ、ちくわ等の水産加工品、チーズ、ハム等の畜産加工品、 漬物、和菓子、洋菓子、その他家畜用の飼料などがある。また、化粧品用としては、 入浴剤、シャンプー、リンス、乳液、ヘアークリーム、 口紅、歯磨き粉などがある。また 、医薬品用としては、うがい薬、食中毒、伝染病用等の内服薬、傷薬、やけど用等の 外用膏薬、点鼻薬などがある。  [0015] The antibacterial agent, the antioxidant, and the antiallergic agent can be used for various uses such as food and drink, cosmetics, and pharmaceuticals. Here, food and drink products include processed agricultural products such as vegetable juice and tofu, processed fishery products such as sausages and chikuwa, processed livestock products such as cheese and ham, pickles, Japanese confectionery, Western confectionery, and other livestock feeds. is there. Cosmetics include bathing agents, shampoos, rinses, emulsions, hair creams, lipsticks and toothpastes. In addition, for pharmaceutical use, there are mouthwash, food poisoning, internal medicine for infectious diseases, wound medicine, external salve for burns, nasal spray and the like.
また、抗腫瘍剤、肝機能障害保護剤の用途は、上記のような飲食用、医薬品用な ど各種の用途が考えられる。  The antitumor agent and hepatic dysfunction protective agent can be used for various uses such as food and drink as described above.
[0016] これらの抗菌剤、抗酸化剤、抗アレルギー剤、抗腫瘍剤、肝機能障害保護剤の剤 形は、その用途や使用状況に応じて、粉末状、顆粒状、タブレット状など各種の形状 とすることができる。  [0016] These antibacterial agents, antioxidant agents, antiallergic agents, antitumor agents, and hepatic dysfunction protective agents have various dosage forms such as powders, granules, tablets, etc., depending on their use and usage. It can be a shape.
実施例 1  Example 1
[0017] 本発明に係る抗菌剤につ!、て、その抗菌性を評価するため、ブラジル産の赤色プ 口ポリスの含有濃度を 100〜5,000 μ g/mLの範囲内で 6段階で変えたとき、培地にお ける供試菌の発育状況がどのように変化するかを調べた。比較のため、キューバ産 の赤色プロポリス、ブラジル産の黄色プロポリスについても同様に測定した。具体的 には、サンプルを 80%エタノール (EtOH)に溶解し、各濃度の混釈培地(平板寒天 培地)に供試菌を接種した後、その発育状況を観察した。この測定結果をまとめて表 1に示す。  [0017] In order to evaluate the antibacterial properties of the antibacterial agent according to the present invention, the concentration of the Brazilian red populus was varied in 6 steps within a range of 100 to 5,000 μg / mL. At this time, it was examined how the growth of the test bacteria in the medium changes. For comparison, the same measurement was performed for Cuban red propolis and Brazilian yellow propolis. Specifically, the sample was dissolved in 80% ethanol (EtOH), and the growth was observed after inoculating the test bacteria on pour medium (plate agar medium) of each concentration. The measurement results are summarized in Table 1.
[0018] なお、ブラジル産の赤色プロポリスにつ!ヽては、サンプル数を 2 (ブラジル赤 (1)、ブ ラジル赤 (2))とし、キューバ産の赤色プロポリスについては、サンプル数を 2 (キューバ 赤 (1)、キューバ赤 (2))とし、ブラジル産の黄色プロポリスについては、サンプル数を 1 ( ブラジル黄色)とした。また、供試菌としては、 Escherichia coli (以下、 E.coliと略称す る。 )、 Peudomonas aeruginosa (以 f、 P.aerugmosaと略称す 。 )、 Enterococcus faec alis (以「、 E. faecahsと略称する。 j、 Staphylococcus aureus (以下、 S. aureusと略称 する。)の 4種類を用いた。 [0018] For Brazilian red propolis, the number of samples is 2 (Brazilian red (1), Brazil red (2)), and for Cuban red propolis, the number of samples is 2 ( Cuban red (1), Cuban red (2)), and for Brazilian yellow propolis, the number of samples is 1 ( Brazil yellow). In addition, Escherichia coli (hereinafter abbreviated as E.coli), Peudomonas aeruginosa (hereinafter abbreviated as P.aerugmosa), Enterococcus faec alis (hereinafter abbreviated as E. faecahs). J, Four types of Staphylococcus aureus (hereinafter abbreviated as S. aureus) were used.
[表 1] 培地中のプロポリス含有濃度 [ a g/mL] *λ サンプル * 供試菌 100 250 500 1 000 2, 500 5 000 [Table 1] Concentration of propolis in the medium [ag / mL] * Lambda sample * Test bacteria 100 250 500 1 000 2, 500 5 000
E.coli 3+ 3+ 2+ + + + キ:ーバ赤 (1)  E.coli 3+ 3+ 2+ + + + Key: Red (1)
P.aeruginosa 3+ 3+ 2+ + + + ϋ. faecalis  P.aeruginosa 3+ 3+ 2+ + + + ϋ. Faecalis
S. aureus  S. aureus
E.coli 3+ 3+ 2+ 2+ 2+ + キニーバ赤 (2)  E.coli 3+ 3+ 2+ 2+ 2+ + Kiniva Red (2)
P.aeruginosa 3+ 3+ 3+ 2+ 2+ + h. faecalis  P.aeruginosa 3+ 3+ 3+ 2+ 2+ + h. Faecalis
S. aureus  S. aureus
E.coli 3+ 3+ 2+ +  E.coli 3+ 3+ 2+ +
ノ ジル赤 (1)  Nozil Red (1)
P.aeruginosa 3+ 3+ 2+ +  P.aeruginosa 3+ 3+ 2+ +
t. faecalis  t. faecalis
S. aureus  S. aureus
E.coli 3+ 3+ 2+ +  E.coli 3+ 3+ 2+ +
マ テジル赤 (2)  Matedil red (2)
P.aeruginosa 3+ 3+ 2+ + P.aeruginosa 3+ 3+ 2+ +
. faecalis  . faecalis
S. aureus  S. aureus
E.coli 3+ 3+ 3+ 3+ 3+ 3+ ジル黄色  E.coli 3+ 3+ 3+ 3+ 3+ 3+ Jill yellow
P.aeruginosa 3+ 3+ 3+ 3+ 3+ 3十 P.aeruginosa 3+ 3+ 3+ 3+ 3+ 30
E. faecalis 2+ + 士 E. faecalis 2+ +
S. aureus 2+ +  S. aureus 2+ +
3+;良好にコロニー形成を認める +;発育が弱いがコロニー形成を認める  3+; good colony formation +; weak growth but colony formation
2+; 1+と 3+の巾間  2+; between 1+ and 3+
土;コロニー形成が不十分だが、 わずかに発育を認める  Soil: Insufficient colony formation, but slightly growing
;発育を全く認めない *Controlはすべて 3+である ; It is all not observed at all the growth * C ontrol is 3+
* キューバ赤;キューバ産紅色のプロポリス * Cuban red; Cuban red propolis
ブラジル赤;ブラジル産紅色のプ口ポリス  Brazilian red; Brazilian red mouth police
ブラジル黄色;ブラジルミナス州産プロボリス  Brazil yellow; Provolis from Minas, Brazil
* * サンプルを 80%EtOHに溶解し、 各濃度の混釈培地を作成した 表 1の結果に基づき、各サンプルにおける供試菌の発育を阻止する最小濃度、つ まり最小発育阻止濃度 (MIC)を求めた。その結果をまとめて表 2に示す。なお、この 最小発育阻止濃度 (MIC)が低値であるほど、そのサンプルの抗菌作用が強いことを 示す。 * * Samples were dissolved in 80% EtOH and pour medium was prepared at each concentration. Based on the results in Table 1, the minimum concentration that inhibits the growth of the test bacteria in each sample, that is, the minimum inhibitory concentration (MIC). Asked. The results are summarized in Table 2. The lower the minimum inhibitory concentration (MIC), the stronger the antibacterial effect of the sample. Show.
[0021] [表 2]  [0021] [Table 2]
単位: g/mL 供試菌 ブラジル黄色 : ,ラジル赤(1)ブラジ 赤 (2) キ バ赤 (1) キ. バ赤 (2) Unit: g / mL Test Bacteria Brazil Yellow:, Rasil Red (1) Brady Red (2) Yellow Red (1) Yellow Red (2)
E.coh 2, 500 2, 500 E.coh 2, 500 2, 500
― * ―  ― * ―
P.aeruginosa 2, 500 2, 500 — * P.aeruginosa 2, 500 2, 500 — *
E. faecalis 1, 000 100以下 100以下 100以下 250E. faecalis 1,000 100 or less 100 or less 100 or less 250
S. aureus 500 100以下 100以下 100以下 100以下S. aureus 500 100 or less 100 or less 100 or less 100 or less
* 5, 000 μ g/mL濃皮において発育阻止を認めない * No growth inhibition in 5,000 μg / mL thick skin
[0022] 表 2から明らかなように、抗菌作用は、ブラジル産の赤色プロポリスが最も強ぐ次い でキューバ産の赤色プロポリスが強ぐブラジル産の黄色プロポリスが最も弱いことが 判明した。 [0022] As is apparent from Table 2, it was found that the antibacterial action was the strongest for Brazilian red propolis, followed by Cuban red propolis, and Brazilian yellow propolis was the weakest.
実施例 2  Example 2
[0023] 実施例 1と同様の方法で、プロポリスの濃度を 40 3000 μ gZmLの範囲で変えて 実験を行い、各種供試菌の最小発育阻止濃度を算出した。供試菌としては、 E.coli P.aeruginosa^ S. aureus ^ Bacillus subtillis (^λ F B. subtillisと略称する。 )、 Candid a albicanc (以下と、 C. albicancと略称する。)の 5種類を用いた。結果を表 3に示す。  [0023] In the same manner as in Example 1, the experiment was carried out with the propolis concentration varied in the range of 40 3000 μg ZmL, and the minimum growth inhibitory concentrations of various test bacteria were calculated. There are five types of test bacteria: E. coli P. aeruginosa ^ S. aureus ^ Bacillus subtillis (abbreviated as ^ λ F B. subtillis) and Candid a albicanc (hereinafter abbreviated as C. albicanc). Was used. The results are shown in Table 3.
[0024] [表 3] 単位: U g/mL 供試菌 ブラジル黄色 ブラジル赤(1 ) ブラジル赤(2) キューバ赤(1 ) [0024] [Table 3] Unit: U g / mL Test bacteria Brazil yellow Brazil red (1) Brazil red (2) Cuba red (1)
E.coli >3000 2500 >3000 >3000 E.coli> 3000 2500> 3000> 3000
P.aeruginose >3000 2500 >3000 >3000  P.aeruginose> 3000 2500> 3000> 3000
S. aureus 500 40 80 80  S. aureus 500 40 80 80
B. subtil lis 2500 500 500 500  B. subtil lis 2500 500 500 500
C. albicanc 500 80 80 80  C. albicanc 500 80 80 80
[0025] すなわち、 E.coli, P.aeruginosaの 2種類の供試菌については、キューバ産の赤色プ 口ポリスやブラジル産の黄色プロポリスでは、最小発育阻止濃度(MIC)が 5,000 μ g ZmLを越えた(5,000 μ gZmLにおいても発育阻止が認められなかった)のに対して 、ブラジル産の赤色プロポリスでは、最小発育阻止濃度(MIC)が 2,500 μ gZmLであ つた o [0026] また、 E. faecalisについては、ブラジル産の黄色プロポリスでは、最小発育阻止濃 度(MIC)が 1,000 μ gZmLであるのに対して、ブラジル産の赤色プロポリスでは、最 小発育阻止濃度 (MIC)が 100 μ gZmL以下と大幅に低下した。 [0025] That is, for the two types of E. coli and P. aeruginosa test strains, the minimum growth inhibitory concentration (MIC) of 5,000 μg ZmL for Cuban red propolis and Brazilian propolis is 5,000 μg ZmL. The Brazilian red propolis had a minimum growth inhibitory concentration (MIC) of 2,500 μgZmL, whereas the growth inhibition was not observed even at 5,000 μgZmL. [0026] As for E. faecalis, the minimum growth inhibitory concentration (MIC) of Brazilian yellow propolis is 1,000 μgZmL, while that of Brazilian red propolis is the minimum growth inhibitory concentration ( MIC) dropped significantly to below 100 μgZmL.
S. aureusについても、ブラジル産の黄色プロポリスでは、最小発育阻止濃度(MIC )が 500 μ gZmLであるのに対して、ブラジル産の赤色プロポリスでは、最小発育阻止 濃度 (MIC)が 40〜80 μ gZmL以下と大幅に低下した。  For S. aureus, Brazilian yellow propolis has a minimum inhibitory concentration (MIC) of 500 μgZmL, while Brazilian red propolis has a minimum inhibitory concentration (MIC) of 40 to 80 μm. It was significantly lower than gZmL.
B. subtillisについても、ブラジル産の黄色プロポリスでは、最小発育阻止濃度(Ml C)が 2500 μ gZmLであるのに対して、ブラジル産の赤色プロポリスでは、最小発育 阻止濃度 (MIC)が 500 μ gZmLと大幅に低下した。  For B. subtillis, Brazilian yellow propolis has a minimum inhibitory concentration (Ml C) of 2500 μgZmL, while Brazilian red propolis has a minimum inhibitory concentration (MIC) of 500 μgZmL. And decreased significantly.
C. albicancについても、ブラジル産の黄色プロポリスでは、最小発育阻止濃度(Ml C)が 500 μ gZmLであるのに対して、ブラジル産の赤色プロポリスでは、最小発育阻 止濃度 (MIC)が 80 μ gZmLと大幅に低下した。  For C. albicanc, Brazilian yellow propolis has a minimum inhibitory concentration (Ml C) of 500 μgZmL, while Brazilian red propolis has a minimum inhibitory concentration (MIC) of 80 μg. It was significantly reduced to gZmL.
[0027] そして、ブラジル産の赤色プロポリスにつ!、ては、その含有濃度が 500 μ gZmL以 上であれば、 6種類すベての供試菌に対して抗菌能が向上し、含有濃度が 1,000 g ZmL以上、 2,500 gZmL以上であれば、その傾向が顕著となる。したがって、ブラ ジル産の赤色プロポリスの最適含有濃度は、抗菌性の観点力 すると、 E. faecalis、 S. aureus、 C. albicancについて用いる際には 100 gZmL以上、 6種類すベての供 試菌種に対して用いる際には 500 gZmL以上(好ましくは、 1,000/z gZmL以上、さ らに好ましくは、 2,500 μ gZmL以上)となる。  [0027] And for Brazilian red propolis! If the concentration is 500 μgZmL or more, the antibacterial activity is improved against all 6 types of test bacteria, If the value is 1,000 g ZmL or more and 2,500 gZmL or more, the tendency becomes remarkable. Therefore, the optimal concentration of red propolis produced in Brazil is 100 gZmL or more when using E. faecalis, S. aureus, and C. albicanc from the viewpoint of antibacterial properties. When used for seeds, it is 500 gZmL or more (preferably 1,000 / z gZmL or more, more preferably 2,500 μgZmL or more).
実施例 3  Example 3
[0028] 赤色プロポリスの抗菌作用につ 、て、上記以外の供試菌を用いて試験を行った。  [0028] The antimicrobial action of red propolis was tested using test bacteria other than those described above.
供試菌としては、 Methicillin Resistant Staphylococcus aureus (メチシリン而ォ '性黄色ブ ドウ球菌、以下、 MRSAと略称する。 ) 、 Methicillin Sensitive Staphylococcus aureus ( メチシリン感受性黄色ブドウ球菌、以下、 MSSAと略称する。 )、 Staphylococcus epider midis (表皮ブドウ球菌)、の 3種類を用いた。ブラジル産の赤色プロポリスの含有濃度 を 200 gZmL、 20 gZmLと変えたとき、培地における供試菌の発育状況がどのよう に変化するかを調べた。比較のため、ブラジル産の黄色プロポリスについても同様に 測定した。具体的には、液ィ匕炭酸ガス抽出したサンプルを 80%エタノール (EtOH) に溶解し、各濃度の混釈培地 (平板寒天培地)に供試菌を接種した後、その発育状 況を観察した。この測定結果を図 4〜図 6に示す。 Examples of the test bacteria include Methicillin Resistant Staphylococcus aureus (methicillin metastatic Staphylococcus aureus, hereinafter abbreviated as MRSA), Methicillin Sensitive Staphylococcus aureus (methicillin-sensitive Staphylococcus aureus, hereinafter abbreviated as MSSA), Three types of Staphylococcus epider midis (Staphylococcus epidermidis) were used. We examined how the growth of the test bacteria in the medium changes when the Brazilian red propolis content is changed to 200 gZmL and 20 gZmL. For comparison, the same measurement was performed for Brazilian yellow propolis. Specifically, the sample extracted with liquid carbon dioxide gas is 80% ethanol (EtOH). After inoculating the test bacteria in pour medium (plate agar medium) of each concentration, the growth state was observed. The measurement results are shown in Figs.
[0029] 図 4〜図 6に示したように、いずれの供試菌においても、赤色プロポリス投与群では 200 gZmLで 80%以上の増殖抑制率を示した。この作用は、従来のプロポリスに比 して高いものであった。 [0029] As shown in Figs. 4 to 6, in any of the test bacteria, the red propolis administration group showed a growth inhibition rate of 80% or more at 200 gZmL. This effect was higher than that of conventional propolis.
実施例 4  Example 4
[0030] 本発明に係る抗酸化剤について、その抗酸化性を評価するため、主に脂溶性物質 を測定する DPPHラジカル消去能を用いて抗酸ィ匕能を測定した。なお、ブラジル産の 赤色プロポリスについては、サンプル数を 2 (ブラジル赤 (1)、ブラジル赤 (2))とし、キュ ーバ産の赤色プロポリスについては、サンプル数を 2 (キューバ赤 (1)、キューバ赤 (2)) とし、ブラジル産の黄色プロポリスについては、サンプル数を 1 (ブラジル黄色)とした  [0030] In order to evaluate the antioxidant properties of the antioxidants according to the present invention, the antioxidant properties were measured using DPPH radical scavenging ability mainly measuring fat-soluble substances. For Brazilian red propolis, the number of samples is 2 (Brazilian red (1), Brazilian red (2)), and for Cuban red propolis, the number of samples is 2 (Cuban red (1), Cuban red (2)) and for Brazilian yellow propolis, the number of samples is 1 (Brazilian yellow)
[0031] その結果を図 1にグラフで示す。図 1のグラフにおいて、縦軸の「1」は、サンプル濃 度 lmgZlOOmLにて ImM DPPHを 50%消去する値を意味する。図 1のグラフから明 らかなように、抗酸ィ匕能は、ブラジル産の赤色プロポリスが最も高ぐ次いでブラジル 産の黄色プロポリスが高ぐキューバ産の赤色プロポリスが最も低いことが判明した。 実施例 5 [0031] The results are shown graphically in FIG. In the graph of FIG. 1, “1” on the vertical axis means a value that erases 50% of ImM DPPH at a sample concentration of lmgZlOOmL. As can be seen from the graph in FIG. 1, it was found that the antioxidant capacity was highest for Brazilian red propolis, followed by Brazilian yellow propolis, and Cuba red propolis being the lowest. Example 5
[0032] 実施例 3と同様に、 DPPHラジカル消去能、及び SOD様活性測定を用いて抗酸ィ匕 能を測定した。 DPPHラジカル消去能については、エタノールを用いての抽出のため 比較的脂溶性の抗酸ィ匕活性を示し、 SOD様活性については水を用いての抽出のた め水溶性の抗酸ィ匕活性を示しているものと考えられる。サンプルとして、プロポリスの 原塊、これを液ィ匕炭酸ガス抽出したもの、及び水抽出したものを用いた。結果を、表 4に示す。  [0032] In the same manner as in Example 3, the DPPH radical scavenging ability and the SOD-like activity measurement were used to measure the antioxidant activity. DPPH radical scavenging activity shows relatively lipid-soluble anti-acid activity due to extraction with ethanol, and SOD-like activity is water-soluble anti-acid activity due to extraction with water It is thought that it shows. As a sample, an original mass of propolis, a liquid carbon dioxide extracted from this, and a water extracted one were used. The results are shown in Table 4.
[0033] [表 4] サンプル 回収率 DPPHラジカル消去能 SOD様活性  [0033] [Table 4] Sample recovery rate DPPH radical scavenging ability SOD-like activity
(%) UNIT(mg/mL) (全活性) Nitrite unit/g (全活性) 原塊 (100) 1.01 1 .01 350.80 350.80 ブラジル赤(1 ) 液化炭酸ガス抽出 40 1.82 0.73 1 39.03 55.61  (%) UNIT (mg / mL) (total activity) Nitrite unit / g (total activity) Raw mass (100) 1.01 1.01 350.80 350.80 Brazilian red (1) Liquefied carbon dioxide extraction 40 1.82 0.73 1 39.03 55.61
水抽出 12 0.03 0.00 1491.06 1 78.92 原塊 (100) 0.73 0.73 243.61 243.61 ブラジル黄色 液化炭酸ガス抽出 35 1.76 0.61 507.65 1 77.68  Water extraction 12 0.03 0.00 1491.06 1 78.92 Bulk (100) 0.73 0.73 243.61 243.61 Brazil yellow Liquefied carbon dioxide extraction 35 1.76 0.61 507.65 1 77.68
水抽出 12 1.20 0.14 2063.52 247.62 [0034] 表 4のように、赤色プロポリスは、原塊の状態で従来のプロポリスに比して脂溶性、 水溶性ともに抗酸ィ匕活性が高いことが判明した。また、 DPPHラジカル消去能は赤色 プロポリスのほうが活性が高いことが判明し、 DPPHラジカル消去能活性は、液ィ匕炭 酸ガス抽出によって約 1. 5倍活性が高まることが判明した。 Water extraction 12 1.20 0.14 2063.52 247.62 [0034] As shown in Table 4, red propolis was found to have higher anti-oxidative activity in both the fat-soluble state and water-soluble state than the conventional propolis in the original state. In addition, DPPH radical scavenging activity was found to be higher in red propolis, and DPPH radical scavenging activity was found to increase by about 1.5 times by extraction with liquid sodium carbonate gas.
実施例 6  Example 6
[0035] 本発明に係る抗アレルギー剤にっ 、て、その抗アレルギー性を評価するため、全 身アナフィラキシーショック誘発マウスを用いて抗アレルギー能を測定した。全身アナ フイラキシーショックの誘発には、マウスに compound48/80を投与した。なお、プロポリ スについては、マウスに経口投与を行うため、原塊力 熱水抽出した水抽出粉末を 使用した。コントロールとして、プロポリスの代わりに水を飲ませたものを対照とした。 結果を表 5に示す。  [0035] In order to evaluate the antiallergic activity of the antiallergic agent according to the present invention, antiallergic ability was measured using whole anaphylactic shock-induced mice. To induce systemic anaphylactic shock, mice were administered compound48 / 80. As for propolis, a water-extracted powder extracted with hot bulk water was used for oral administration to mice. As a control, a control that was given water instead of propolis was used as a control. The results are shown in Table 5.
[0036] [表 5] 生存率 (%)  [0036] [Table 5] Survival rate (%)
サンプル ie20 i260 Sample i e 20 i 2 60
Control 0 0  Control 0 0
Figure imgf000012_0001
表 5のように、 Control群はアナフィラキシーショック誘発後、 20分後に全滅したが、 プロポリス投与群は全滅しな力つた。また、赤色プロポリスのほうが従来のプロポリスよ りも高い生存率を示し、サンプル濃度が高くなるほど生存率が高くなることが判明した 実施例 7
Figure imgf000012_0001
As shown in Table 5, the Control group was annihilated 20 minutes after induction of anaphylactic shock, whereas the Propolis administration group was completely annihilated. It was also found that red propolis showed a higher survival rate than conventional propolis, and the higher the sample concentration, the higher the survival rate. Example 7
[0038] 本発明に係る肝機能障害保護剤について、その肝機能障害保護作用を評価する ため、実験的肝障害誘発ラットを用いて肝機能障害保護作用を測定した。実験的肝 障害誘発誘発には、ラットに四塩ィ匕炭素を投与した。  [0038] In order to evaluate the liver dysfunction protective action of the liver dysfunction protective agent according to the present invention, the liver dysfunction protective action was measured using experimental hepatopathy-induced rats. Rats were administered tetrasalt carbon dioxide to induce experimental liver injury.
6週齢の Wistar系雄性ラットを、 1週間の予備飼育の後体重が均等になるようにグ ループ分けをし、 control群、黄色プロポリス群、赤色プロポリス群とした (n= 8)。プ 口ポリス投与群には、黄色および赤色プロポリス熱水抽出物を 200mgZkgZdayの 用量にて金属性胃ゾンデを用いて 8日間連日強制経口投与を行った。 control群に は精製水 lmlを投与した。最終投与ののち 12時間以上の絶食を行い、体重 100gあ たり 0. 05mlCC14/0. 2mlォリーブオイルを経口投与し、 24時間後の血清中の GP T、 GOTを測定した。結果を図 7に示す。  Six-week-old Wistar male rats were grouped so that their body weights were equalized after one week of preliminary breeding, and were divided into control group, yellow propolis group, and red propolis group (n = 8). In the oral police administration group, yellow and red propolis hot water extracts were administered by oral gavage daily for 8 days using a metal gastric sonde at a dose of 200 mgZkgZday. In the control group, 1 ml of purified water was administered. After the final administration, the animals were fasted for 12 hours or longer, 0.05 ml CC14 / 0.2 ml olive oil per 100 g body weight was orally administered, and serum GPT and GOT were measured 24 hours later. The results are shown in FIG.
[0039] GPT値は control、黄色プロポリス、赤色プロポリス投与群の順にそれぞれ、 549  [0039] The GPT value was 549 in the order of control, yellow propolis, and red propolis, respectively.
± 216 (mean士 SD ;以下同様)、 471 ± 160、 307 ± 59IU/Lであった。  ± 216 (mean SD; the same applies hereinafter), 471 ± 160, 307 ± 59 IU / L.
これら control群の GOT値、 GPT値をそれぞれ 100%とすると、 GOT値については 、従来の黄色プロポリス投与群で 31. 9%、赤色プロポリス投与群では 44. 6%の抑 制が見られ、 GPT値については、黄色プロポリス投与群が 18. 4%、赤色プロポリス 投与群で 46. 9%の抑制が見られた。特に、赤色プロポリス投与群は control群に対 して有意に低値を示した (Pく 0.05)。このことから、本発明にて用いられる赤色プロポリ スには従来の黄色プロポリスより強力な肝機能障害保護作用があることが示された。 実施例 8  Assuming that the GOT value and GPT value of these control groups are 100%, the GOT value was suppressed by 31.9% in the conventional yellow propolis administration group and 44.6% in the red propolis administration group. Regarding the value, 18.4% of suppression was observed in the yellow propolis administration group and 46.9% suppression in the red propolis administration group. In particular, the red propolis administration group was significantly lower than the control group (P 0.05). From this, it was shown that the red propolis used in the present invention has a stronger liver dysfunction protective effect than the conventional yellow propolis. Example 8
[0040] 本発明に係る抗腫瘍剤について、その抗腫瘍作用を評価するため、試験を行った 近交系マウス C57BLZ6N、雌、 6週齢を 1週間予備飼育し、各群の平均体重が一 致するように 1群 10匹で、 6群を構成した。検体として、 control (精製水)、他社プロ ポリス製品のプロポリス A (製造:協和発酵工業株式会社、販売:株式会社サンヘル ス)、および本発明の赤色プロポリス熱水抽出物を用意し、各検体をマウスの体重に 対して 800mg/kgになるように調製し、経口ゾンデを用いて 1日 1回の経口投与を 開始した。投与開始 8日目(dayOとする)腰背部に EL— 4 (マウスリンパ腫)を 1. 5 X 104cells/0. 2mlZheadの割合で皮下投与による接種を行った。検体の投与を継 続し、腫瘍容積量 (長径 X短径)を測定した。 dayl7に各マウスを頸椎脱臼にて屠殺 した後、脾臓、胸腺及び腫瘍を摘出し重量測定を行った。結果を表 6、および図 8〖こ 示す。 [0040] In order to evaluate the antitumor activity of the antitumor agent according to the present invention, the inbred mouse C57BLZ6N, female, and 6 weeks of age tested were preliminarily raised for one week, and the average body weight of each group was one. Six groups were composed of 10 animals per group. As samples, prepare control (purified water), propolis A of other companies' propolis products (manufacturing: Kyowa Hakko Kogyo Co., Ltd., sales: San Hells Co., Ltd.), and red propolis hot water extract of the present invention. Prepare a mouse body weight of 800 mg / kg and administer once a day using an oral sonde. Started. On day 8 of administration (dayO), EL-4 (mouse lymphoma) was inoculated subcutaneously at a ratio of 1.5 X 104 cells / 0.2 mlZhead on the back of the lumbar region. The sample administration was continued and the tumor volume (major axis X minor axis) was measured. On dayl7, each mouse was sacrificed by cervical dislocation, and then the spleen, thymus and tumor were removed and weighed. The results are shown in Table 6 and Fig. 8.
[0041] [表 6] [0041] [Table 6]
Figure imgf000014_0001
Figure imgf000014_0001
[0042] 表 6、及び図 8に示すように、 control群に比較して、他社製品では 12. 1%、本発 明の赤色プロポリス熱水抽出物においては 54. 7%の腫瘍増殖抑制効果が見られた 。このように、本発明の赤色プロポリス由来抗腫瘍剤には高い抗腫瘍効果が期待で きることが判明した。  [0042] As shown in Table 6 and Fig. 8, compared to the control group, the tumor growth inhibitory effect was 12.1% for the other company's product and 54.7% for the red propolis hot water extract of the present invention. It was observed . Thus, it has been found that the red propolis-derived antitumor agent of the present invention can be expected to have a high antitumor effect.
産業上の利用可能性  Industrial applicability
[0043] 本発明の赤色プロポリスが原材料として含まれている機能性飲食品は、十分な抗 菌作用、抗酸化作用、抗アレルギー作用、抗腫瘍作用、又は肝機能障害保護作用 を備えた機能性飲食品を比較的容易に提供することができる。この飲食品を摂取す ることで、健康を増進することが可能となる。  [0043] The functional food or drink product containing the red propolis of the present invention as a raw material has a sufficient antibacterial action, antioxidant action, antiallergic action, antitumor action, or liver dysfunction protective action. Food and drink can be provided relatively easily. Taking these foods and drinks can improve your health.
[0044] また、特定の起源植物由来の赤色プロポリスが有効成分として含まれて 、る抗菌剤 、抗酸化剤、抗アレルギー剤、抗腫瘍剤、又は肝機能障害保護剤を提供できるため 、十分な機能性を備え、かつ安全性、実用性にも優れた安全な抗菌剤、抗酸化剤、 抗アレルギー剤、抗腫瘍剤、又は肝機能障害保護剤を提供することができる。  [0044] Further, since red propolis derived from a plant of a specific origin is contained as an active ingredient, an antibacterial agent, an antioxidant, an antiallergic agent, an antitumor agent, or a liver dysfunction protective agent can be provided. It is possible to provide a safe antibacterial agent, antioxidant, antiallergic agent, antitumor agent, or liver dysfunction protective agent that has functionality and is excellent in safety and practicality.

Claims

請求の範囲 The scope of the claims
[1] 赤色プロポリスが原材料として含まれて 、る飲食品であって、  [1] A food or drink containing red propolis as a raw material,
目 ij ti赤色フ—口ホリスは、 Strypnnodendron aastnngens^ ¾chinus molie、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes ij ti red-mouthed hollis is characterized by having at least one of Strypnnodendron aastnngens ^ ¾chinus molie, Rhi zophora mangle, and Manikara elata as origin plant,
前記飲食品は抗菌作用、抗酸化作用、抗アレルギー作用、抗腫瘍作用、又は肝機 能障害保護作用のいずれか 1つ以上の機能性作用を有することを特徴とする飲食品  The food or drink has one or more functional actions of antibacterial action, antioxidant action, antiallergic action, antitumor action, or liver dysfunction protecting action.
[2] 前記赤色プロポリスは、紫外部吸収スペクトルで、波長 280nm付近に吸光度の極 大値を持ち、近傍の安定域の吸光度との比が 1以上であり、かつ可視部吸収スぺタト ルで、波長 500nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 1に記載の飲食品。 [2] The red propolis has an absorption spectrum at a wavelength around 280 nm in the ultraviolet absorption spectrum, a ratio of the absorbance in the vicinity of the stable region is 1 or more, and a visible absorption spectrum. 2. The food or drink according to claim 1, wherein the food or drink has a maximum absorbance in the vicinity of a wavelength of 500 nm and a ratio of the absorbance in the vicinity of the stable region is 5 or more.
[3] 赤色プロポリスが有効成分として含まれて 、る抗菌剤であって、  [3] An antibacterial agent containing red propolis as an active ingredient,
目 ij ti赤色フ—口ホリスは、 Strypnnodendron aastnngens^ ¾chinus molie、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes ij ti red-mouthed hollis is characterized by having at least one of Strypnnodendron aastnngens ^ ¾chinus molie, Rhi zophora mangle, and Manikara elata as origin plant,
前記抗菌剤は飲食品用、化粧品用または医薬品用であることを特徴とする抗菌剤  The antibacterial agent is for foods and drinks, cosmetics or pharmaceuticals
[4] 前記赤色プロポリスは、紫外部吸収スペクトルで、波長 280nm付近に吸光度の極 大値を持ち、近傍の安定域の吸光度との比が 1以上であり、かつ可視部吸収スぺタト ルで、波長 500nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 3に記載の抗菌剤。 [4] The red propolis has an absorption spectrum at a wavelength near 280 nm in the ultraviolet absorption spectrum, a ratio of 1 or more to the absorbance in the nearby stable region, and a visible absorption spectrum. 4. The antibacterial agent according to claim 3, wherein the antibacterial agent has a maximum value of absorbance near a wavelength of 500 nm and a ratio of the absorbance in the vicinity of the stable region is 5 or more.
[5] 赤色プロポリスが有効成分として含まれて 、る抗酸化剤であって、  [5] An antioxidant containing red propolis as an active ingredient,
目 ij ti赤色フ—口ホリスは、 Strypnnodendron aastnngens^ ¾chinus molie、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes ij ti red-mouthed hollis is characterized by having at least one of Strypnnodendron aastnngens ^ ¾chinus molie, Rhi zophora mangle, and Manikara elata as origin plant,
前記抗酸化剤は飲食品用、化粧品用または医薬品用であることを特徴とする抗酸 化剤 Q Antioxidant Q characterized in that the antioxidant is for food and drink, cosmetics or pharmaceuticals.
[6] 前記赤色プロポリスは、紫外部吸収スペクトルで、波長 280nm付近に吸光度の極 大値を持ち、近傍の安定域の吸光度との比が 1以上であり、かつ可視部吸収スぺタト ルで、波長 500nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 5に記載の抗酸化剤。 [6] The red propolis has an absorption spectrum at a wavelength near 280 nm in the ultraviolet absorption spectrum, a ratio of the absorbance in the vicinity of the stable region is 1 or more, and a visible absorption spectrum. 6. The antioxidant according to claim 5, wherein the antioxidant has a maximum absorbance near a wavelength of 500 nm and has a ratio of 5 or more to the absorbance in the nearby stable region.
[7] 赤色プロポリスが有効成分として含まれて 、る抗アレルギー剤であって、  [7] An anti-allergic agent containing red propolis as an active ingredient,
目 ij ti赤色フ—口ホリスは、 Strypnnodendron aastnngens^ ¾chinus molie、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes ij ti red-mouthed hollis is characterized by having at least one of Strypnnodendron aastnngens ^ ¾chinus molie, Rhi zophora mangle, and Manikara elata as origin plant,
前記抗アレルギー剤は飲食品用、化粧品用または医薬品用であることを特徴とす る抗アレルギー剤。  The antiallergic agent is characterized in that the antiallergic agent is for foods and drinks, cosmetics or pharmaceuticals.
[8] 前記赤色プロポリスは、紫外部吸収スペクトルで、波長 280nm付近に吸光度の極 大値を持ち、近傍の安定域の吸光度との比が 1以上であり、かつ可視部吸収スぺタト ルで、波長 500nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 7に記載の抗アレルギー剤。  [8] The red propolis has an absorption spectrum at a wavelength near 280 nm in the ultraviolet absorption spectrum, a ratio of the absorbance in the vicinity of the stable region is 1 or more, and a visible absorption spectrum. 8. The antiallergic agent according to claim 7, wherein the antiallergic agent has a maximum absorbance in the vicinity of a wavelength of 500 nm and a ratio of the absorbance in the vicinity of the stable region is 5 or more.
[9] 赤色プロポリスが有効成分として含まれて 、る抗腫瘍剤であって、  [9] An antitumor agent comprising red propolis as an active ingredient,
目 ij ti赤色フ—口ホリスは、 Strypnnodendron aastnngens^ ¾chinus molie、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes ij ti red-mouthed hollis is characterized by having at least one of Strypnnodendron aastnngens ^ ¾chinus molie, Rhi zophora mangle, and Manikara elata as origin plant,
前記抗腫瘍剤は飲食品用または医薬品用であることを特徴とする抗腫瘍剤。  The antitumor agent is for food or drink or for pharmaceuticals.
[10] 前記赤色プロポリスは、紫外部吸収スペクトルで、波長 280nm付近に吸光度の極 大値を持ち、近傍の安定域の吸光度との比が 1以上であり、かつ可視部吸収スぺタト ルで、波長 500nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 9に記載の抗腫瘍剤。 [10] The red propolis has an absorption spectrum at a wavelength near 280 nm in the ultraviolet absorption spectrum, a ratio of the absorbance in the vicinity of the stable region is 1 or more, and a visible absorption spectrum. 10. The antitumor agent according to claim 9, wherein the antitumor agent has a maximum absorbance in the vicinity of a wavelength of 500 nm and a ratio of the absorbance in the vicinity of the stable region is 5 or more.
[11] 赤色プロポリスが有効成分として含まれている肝機能障害保護剤であって、 [11] A liver dysfunction protective agent containing red propolis as an active ingredient,
目 ij ti赤色フ—口ホリスは、 Strypnnodendron aastnngens^ ¾chinus molie、 Rhi zophora mangle、及び Manikara elataのうち少なくとも 1つ以上を起源植物とす ることを特徴とし、  Eyes ij ti red-mouthed hollis is characterized by having at least one of Strypnnodendron aastnngens ^ ¾chinus molie, Rhi zophora mangle, and Manikara elata as origin plant,
前記肝機能障害保護剤は飲食品用または医薬品用であることを特徴とする肝機能 障害保護剤。 The liver function disorder protective agent is for food and drink or for pharmaceuticals Obstacle protectant.
前記赤色プロポリスは、紫外部吸収スペクトルで、波長 280nm付近に吸光度の極 大値を持ち、近傍の安定域の吸光度との比が 1以上であり、かつ可視部吸収スぺタト ルで、波長 500nm付近に吸光度の極大値を持ち、近傍の安定域の吸光度との比が 5以上であることを特徴とする請求項 11に記載の肝機能障害保護剤。  The red propolis has a maximum absorbance at a wavelength of about 280 nm in the ultraviolet absorption spectrum, a ratio of 1 or more to the absorbance in the nearby stable region, and a visible absorption spectrum at a wavelength of 500 nm. 12. The liver dysfunction protective agent according to claim 11, which has a local maximum absorbance and has a ratio of 5 or more to the absorbance in the nearby stable region.
PCT/JP2005/018633 2004-10-07 2005-10-07 Functional food and drink WO2006038690A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006539345A JPWO2006038690A1 (en) 2004-10-07 2005-10-07 Functional food and drink

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004295472 2004-10-07
JP2004-295472 2004-10-07

Publications (1)

Publication Number Publication Date
WO2006038690A1 true WO2006038690A1 (en) 2006-04-13

Family

ID=36142760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/018633 WO2006038690A1 (en) 2004-10-07 2005-10-07 Functional food and drink

Country Status (2)

Country Link
JP (1) JPWO2006038690A1 (en)
WO (1) WO2006038690A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008011806A (en) * 2006-07-07 2008-01-24 Api Co Ltd Propolis composition, and health food of the same
JP2011050376A (en) * 2009-08-07 2011-03-17 Api Co Ltd Method for producing retusapurpurin a extracted from red propolis raw mass, and method for assessing red propolis extract using the retusapurpurin a
JP2012077042A (en) * 2010-10-04 2012-04-19 Kobayashi Pharmaceutical Co Ltd Anti-saccharification agent
KR101760691B1 (en) * 2014-09-26 2017-07-24 연천군 Health functional food for preventing pancreatic adenocarcinoma
KR101769774B1 (en) * 2014-09-26 2017-08-30 연천군 Health functional food for preventing or treatment tumor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001321093A (en) * 2000-05-10 2001-11-20 Oubiken:Kk Refined propolis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001321093A (en) * 2000-05-10 2001-11-20 Oubiken:Kk Refined propolis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DA SILVA CUNHA I.B. ET AL: "Antitypanosomal activity of Brazilian propolis from Apis mellifera", CHEM.PHARM.BULL., vol. 52, no. 5, May 2004 (2004-05-01), TOKYO, pages 602 - 604, XP003006471 *
JAPAN APPLIED MICROBIOLOGY INSTITUTE: "THE RED PROPOLIS", 26 November 2004, DIAMOND, INC., article PARK Y.K., pages: 5 - 44 - 140-160, XP003006470 *
LEDON N. ET AL: "Antipsoriatic, anti-inflammentory, and analgesic effects of an extract of re propolis", ACTA PHARMACOLOGICA SINICA, vol. 18, no. 3, 1997, pages 274 - 276, XP003006473 *
RODRIGUEZ S. ET AL: "Effects of Cuban red propolis on galactosamine-induced hepatitis in rats", PHARMACOL. RES., vol. 35, no. 1, 1997, pages 1 - 4, XP003006472 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008011806A (en) * 2006-07-07 2008-01-24 Api Co Ltd Propolis composition, and health food of the same
JP2011050376A (en) * 2009-08-07 2011-03-17 Api Co Ltd Method for producing retusapurpurin a extracted from red propolis raw mass, and method for assessing red propolis extract using the retusapurpurin a
JP2012077042A (en) * 2010-10-04 2012-04-19 Kobayashi Pharmaceutical Co Ltd Anti-saccharification agent
KR101760691B1 (en) * 2014-09-26 2017-07-24 연천군 Health functional food for preventing pancreatic adenocarcinoma
KR101769774B1 (en) * 2014-09-26 2017-08-30 연천군 Health functional food for preventing or treatment tumor

Also Published As

Publication number Publication date
JPWO2006038690A1 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
Rahmani et al. Pharmacological and therapeutic potential of neem (Azadirachta indica)
Waris et al. Green fabrication of Co and Co3O4 nanoparticles and their biomedical applications: A review
Rahman et al. Therapeutic potential of Aegle marmelos (L.)-An overview
Kumar et al. Pharmacological and therapeutic effects of triphala –A literature review
Singh et al. Oral mucositis
WO2006038690A1 (en) Functional food and drink
AU2018244983B2 (en) Antimicrobial garlic compositions
CN101428057A (en) Antimicrobial powder for reinforcing immune, strengthening the body resistance and removing toxicity for livestock and poultry
Mardani et al. Comparison of anti-Candida activities of the ancient plants Lawsonia inermis and Ziziphus spina christi with antifungal drugs in Candida species isolated from oral cavity
JP2010540566A5 (en)
Celiksoy et al. Antimicrobial potential of pomegranate extracts
JP2018519361A (en) Formulations for the treatment of oral, throat and airway disorders
Niculescu et al. Natural compounds for preventing ear, nose, and throat-related oral infections
Chiller et al. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans
WO2004112773A1 (en) Pharmaceutical compositions used for immune disease treatment and improvement
Singh et al. Cytotoxicity, antimicrobial, anti-inflammatory and antioxidant activity of camellia sinensis and citrus mediated copper oxide nanoparticle—An in vitro study
US20190247360A1 (en) Pharmaceutical Composition for Treating Bacterial and Viral infections
CN101711758A (en) Application of apigenin in preparing medicament for preventing and treating diseases caused by ischemic injuries of humans
KR102228770B1 (en) Anti-microbial composition comprising rosemary extract and ascorbic acid as active ingredient
Singh et al. Lycopene in oral diseases
Patil et al. Honey and its uses in oral diseases-An overview
Petry et al. Medicinal herbs: answers and advice, part 1
KR101436923B1 (en) Antibacterial oral composition containg cirsium sp exctract
KR102066821B1 (en) Natural Complex Cosmetic Preservative Composition
KR20190014873A (en) Antibacterial composition comprising an extract of quercus salicina nut and banaba leaf

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006539345

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05790647

Country of ref document: EP

Kind code of ref document: A1